The LGALS3 gene gives your body instructions to make galectin-3, a protein that helps cells stick, communicate, and respond to injury or infection. It also supports inflammation control and tissue repair. If this gene does not work normally, immune signaling and healing can become less balanced, which may contribute to scarring in organs such as the heart, kidneys, or liver. Some variants in the LGALS3 gene may influence these risks, but they do not by themselves diagnose a disease.
What is a gene?
Genes are stretches of DNA that carry instructions your cells use to make molecules or regulate processes in the body. Some genes provide the directions for producing proteins, which are the working parts of cells. Others are used mainly to control when certain processes happen, where they take place, and how active they are. Taken together, genes affect how the body grows and works, and they can also influence how you respond to food, stress, and medications. To go deeper into this subject, you can find more in the LearnHub.
Overview
LGALS3Gene function
What if the gene works
The LGALS3 gene helps make galectin-3, a protein that lets cells stick, signal, and interact with the immune system. It also supports tissue repair and the body’s response to inflammation.
Risk
What if the gene does not work
Changes in the LGALS3 gene can reduce or alter galectin-3 activity, affecting how cells stick, signal, and handle inflammation. Milder variants may have small effects, while more severe variants can disrupt these cell-to-cell and immune response processes more clearly.
Treatment
What does that mean for your treatment
No LGALS3-specific treatment or drug-choice approach is currently established in clinical guidelines for people with a pathogenic or loss-of-function variant in the LGALS3 gene. The LGALS3 gene is being studied mainly as a biomarker and possible drug target in heart failure, fibrosis, and some cancers.
Gene function
What if the gene works
Your cells make galectin-3 from the LGALS3 gene, a protein that helps cells communicate and interact with their surroundings. It works both inside cells and on their surface. In your body, the LGALS3 gene supports everyday immune activity, tissue upkeep, and cell behavior. This helps explain what the LGALS3 gene does in the body each day.
Galectin-3 helps cells attach to nearby cells and to the support material around them. This steady contact helps tissues keep their shape and supports controlled cell movement.
This protein helps pass messages between cells and their environment. These signals influence everyday cell actions, including growth, movement, and when a cell stays in place.
In the immune system, galectin-3 helps white blood cells recognize microbes and respond to tissue stress. It also helps coordinate inflammation, the body's controlled response to infection or injury.
Some immune cells use galectin-3 while surrounding and clearing germs, worn-out cells, and debris. This cleanup supports tissue maintenance after normal daily wear.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variation in appearance, metabolism, and the way the body responds to environmental influences. Many have no noticeable effect and simply represent natural genetic variation. In some situations, though, a variant changes how a gene works more significantly and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the LGALS3 gene can change how much galectin-3 a cell makes or how well the protein folds, stays stable, and attaches to partner molecules. In practical terms, LGALS3 gene variant effects range from mild changes that slightly reduce activity to more severe variants that truncate the protein, lower its stability, or weaken key binding surfaces. These differences can alter where the protein ends up in the cell and how strongly it interacts with other proteins and cell membranes.
How variants are linked to conditions
Variants in the LGALS3 gene do not yet have a broadly confirmed link to a specific health condition, although research on how variants of the LGALS3 gene are linked to conditions is still developing. If you have a confirmed LGALS3 result on genetic testing, your doctor or genetic counselor can explain what it may mean for you in the context of your personal and family history.
A variant is not necessarily a diagnosis
Genetic variants are a usual feature of human biology and are widely seen in the general population. Most do not have a direct effect on health and instead reflect normal human diversity. For many genes, carrying a variant associated with a condition indicates a possible link rather than a definite diagnosis, especially when several genes and environmental factors are also involved. In other cases, though, a single well-characterized variant in a specific gene can be enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the LGALS3 gene itself. Some changes in this gene have been studied in heart, kidney, and inflammatory conditions, but their effect on personal risk is still unclear. Anyone with concerns about family history or genetic results should speak with a doctor or genetic counselor.
Inheritance of LGALS3 variants
There is not yet a broadly confirmed Mendelian inheritance pattern for LGALS3-related disease, so the way LGALS3 gene variants are inherited is not tied to one clearly established dominant, recessive, or X-linked condition. The LGALS3 gene is located on chromosome 14, which is an autosome. That means you inherit one copy of the LGALS3 gene from your mother and one copy from your father.
What does my LGALS3 result mean for my family?
There is not yet a broadly confirmed inherited pattern linking LGALS3 to a specific single-gene condition. If you have a specific LGALS3 result and want to understand what it could mean for close relatives, a doctor or genetic counselor can help explain it in the context of your personal and family history.
Genetic information
Genetic testing
How you find out about variants
To look for variants in the LGALS3 gene, genetic testing reads DNA from a blood sample, saliva sample, or cheek swab and checks the gene's sequence for differences. LGALS3 genetic testing may be done as part of a multigene panel, exome test, or whole genome test, depending on why testing is being done.
When should I consider getting a genetic test?
There isn't yet a broadly established, LGALS3-specific clinical reason for testing. Decisions about genetic testing are best made with a doctor or genetic counselor based on your health history and family history.
A genetic result is only one part of your health story
How much a genetic result can tell you varies with the condition and with the type of variant involved, even though it can provide useful insight. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. For some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood along with other parts of care. In other situations, a genetic result may offer a clear answer. In areas such as medication response, genetic results can also help put your individual experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Some people break down a medication faster or slower than others, while some are more or less sensitive to its effects. This helps explain why the same treatment can work well for one person, seem weaker for another, or cause more side effects in someone else.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences can affect the way a person responds to medications. It studies links between genes and drugs to better explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how strongly a drug works or how the body handles it. This information can help guide treatment decisions that are more informed and more personalized. More detailed information on this topic is available in the LearnHub.
Drugs influenced by the LGALS3 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choices, so questions about side effects, benefits, or changes to your treatment are best discussed with your doctor. LGALS3 has been studied in research on inflammation, heart disease, and cancer, but these findings are not currently used to guide routine prescribing.
History
In recent decades, awareness of this gene’s role has grown. The LGALS3 gene was identified during research on a family of sugar-binding proteins later called galectins, and galectin-3 became one of the best studied members of that group. Early laboratory work described the same protein under different names, including Mac-2 and CBP35, before naming became more standardized. As medical science evolved, so did understanding of this gene. By the 1990s and 2000s, research linked galectin-3 to inflammation, scarring, cancer biology, and heart disease, which brought it into both basic science and clinical research. These historical steps shaped today’s understanding of the LGALS3 gene as an important part of cell signaling and disease studies.